Hongyu Liu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Gut-bone axis: mechanisms and intervention effects of Chinese botanical drugs in osteoporosis management.
Journal: Frontiers in pharmacology
Published: March 29, 2026
Mitigating mitochondrial dysfunction: a novel strategy for Chinese botanical drugs against osteoporosis.
Journal: Frontiers in pharmacology
Published: February 12, 2026
Pharmacological potential of Chinese botanical drugs in managing chronic kidney disease by targeting mitochondrial quality control.
Journal: Frontiers in pharmacology
Published: October 15, 2025
Identification of Cystatin 3 as a Potential Diagnostic Biomarker for Osteoporosis Using Machine Learning.
Journal: Journal of inflammation research
Published: October 02, 2025
Correction: Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1.
Journal: Journal of translational medicine
Published: May 09, 2025
A facile method to fabricate syndiotactic polystyrene aerogels by freeze-drying.
Journal: Soft matter
Published: April 04, 2025
Synthesis and Characterization of Ultralight Syndiotactic Polystyrene Aerogels Prepared by Freeze-Drying.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: March 14, 2025
Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1.
Journal: Journal of translational medicine
Published: November 27, 2024
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis.
Journal: Frontiers in pharmacology
Published: January 18, 2024
Salidroside alleviates dexamethasone-induced inhibition of bone formation via transforming growth factor-beta/Smad2/3 signaling pathway.
Journal: Phytotherapy research : PTR
Published: August 21, 2022
Novel Sigma-2 receptor ligand A011 overcomes MDR in adriamycin-resistant human breast cancer cells by modulating ABCB1 and ABCG2 transporter function.
Journal: Frontiers in pharmacology
Published: May 25, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026